Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA ...Middle East

PR Newswire - News
Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA
GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration...

Hence then, the article about fermion announces ind approval of non addictive pain relief drug fz008 145 by china nmpa was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA )

Apple Storegoogle play

Last updated :

Also on site :



Latest News